Valion Bio (VBIO) Depreciation & Amortization (CF) (2023 - 2025)

Valion Bio has reported Depreciation & Amortization (CF) for 3 years, with the latest figure at $1000.0 in Q2 2025.

• On a quarterly basis, Depreciation & Amortization (CF) changed 0.0% year-over-year to $1000.0 in Q2 2025; TTM through Jun 2026 was $1000.0, a 66.67% decrease from a year earlier, with the FY2024 full-year figure at $3000.0, down 62.5% from the prior year.
• Depreciation & Amortization (CF) was $1000.0 for Q2 2025 at Valion Bio, roughly flat from $1000.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $3000.0 in Q2 2023, with the low at $1000.0 in Q3 2023.
• Average Depreciation & Amortization (CF) over 3 years is $1444.4, with a median of $1000.0 recorded in 2023.
• The largest YoY upside for Depreciation & Amortization (CF) was 0.0% in 2024 against a maximum downside of 66.67% in 2024.
• Over 3 years, Depreciation & Amortization (CF) stood at $2000.0 in 2023, then slumped by 50.0% to $1000.0 in 2024, then changed by 0.0% to $1000.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $1000.0 (Q2 2025), $1000.0 (Q1 2025), and $1000.0 (Q3 2024), per Business Quant data.